Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs
DOI:
https://doi.org/10.2340/actadv.v104.41184Keywords:
atopic dermatitis, corticophobia, eczema, therapeutic patient education, quality of lifeAbstract
In the era of biological treatments and small molecules, this study assessed therapeutic patient education (TPE) in managing adult atopic dermatitis (AD), focusing on disease severity, quality of life, and the use of systemic treatments. This multicentre study included 260 adult AD patients, with 184 undergoing a full TPE programme and 76 control patients. Evaluations included disease severity, quality of life (DLQI), and systemic treatment use. The primary goal was to measure AD improvement, with secondary goals assessing DLQI score changes and systemic treatment use. AD severity improved in 64.7% of TPE patients vs 45.7% of controls (p = 0.008). The mean DLQI score dropped by 5.7 points in the TPE group vs 2.4 points in controls (p = 0.006). Additionally, 69.8% of TPE patients had a DLQI score ≤ 4/30 compared with 50% of controls (p = 0.025). Regarding therapeutics, 83.6% of patients naive to systemic treatment at inclusion were maintained exclusively under topical treatment vs 21.7% in the control group. The likelihood of needing systemic treatment was 66% in controls vs 6% in the TPE group. TPE enhances AD severity and quality of life, ensures better disease control, and reduces systemic treatment use, highlighting its importance in managing adult AD.
Downloads
References
Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy 2018; 73: 1284-1293.
https://doi.org/10.1111/all.13401 DOI: https://doi.org/10.1111/all.13401
Kowalska-Olędzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J Drug Assess 2019; 8: 126-128.
https://doi.org/10.1080/21556660.2019.1619570 DOI: https://doi.org/10.1080/21556660.2019.1619570
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet 2020; 396:345-360.
https://doi.org/10.1016/S0140-6736(20)31286-1 DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Weidinger S, Novak N. Atopic dermatitis. The Lancet 2016; 387: 1109-1122.
https://doi.org/10.1016/S0140-6736(15)00149-X DOI: https://doi.org/10.1016/S0140-6736(15)00149-X
Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Severity strata for Eczema Area and Severity Index ( EASI ), modified EASI , Scoring Atopic Dermatitis ( SCORAD ), objective SCORAD , Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol 2017; 177: 1316-1321.
https://doi.org/10.1111/bjd.15641 DOI: https://doi.org/10.1111/bjd.15641
Stalder J-F, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe: PO-SCORAD self-assessment scale validation. Allergy 2011; 66: 1114-1121.
https://doi.org/10.1111/j.1398-9995.2011.02577.x DOI: https://doi.org/10.1111/j.1398-9995.2011.02577.x
Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol 2022; 36: 1409-1431.
https://doi.org/10.1111/jdv.18345 DOI: https://doi.org/10.1111/jdv.18345
Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline ( EUROGUIDERM ) on atopic eczema - part II : non‐systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol 2022; 36: 1904-1926.
https://doi.org/10.1111/jdv.18429 DOI: https://doi.org/10.1111/jdv.18429
Arents BWM, van Zuuren EJ, Vermeulen S, Schoones JW, Fedorowicz Z. Global Guidelines in Dermatology Mapping Project ( GUIDEMAP ), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based ( CUTE )?*. Br J Dermatol 2022; 186: 792-802.
https://doi.org/10.1111/bjd.20972 DOI: https://doi.org/10.1111/bjd.20972
Yin LJ, Wei TK, Choi E, Chandran NS. TOPICOP © scale for steroid phobia - difficulties and suggestions for application in clinical research. J Dermatol Treat 2020; 31: 624-625.
https://doi.org/10.1080/09546634.2019.1657221 DOI: https://doi.org/10.1080/09546634.2019.1657221
Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema: corticosteroid phobia in atopic eczema. Br J Dermatol 2000; 142: 931-936.
https://doi.org/10.1046/j.1365-2133.2000.03473.x DOI: https://doi.org/10.1046/j.1365-2133.2000.03473.x
Langenbruch A, Radtke M, Franzke N, Ring J, Foelster-Holst R, Augustin M. Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. J Eur Acad Dermatol Venereol 2014; 28: 719-726.
https://doi.org/10.1111/jdv.12154 DOI: https://doi.org/10.1111/jdv.12154
Thyssen JP, Hamann CR, Linneberg A, Dantoft TM, Skov L, Gislason GH, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy 2018; 73: 214-20.
https://doi.org/10.1111/all.13231 DOI: https://doi.org/10.1111/all.13231
Weil C, Sugerman PB, Chodick G, Liang H, Wang H, Calimlim BM, et al. Epidemiology and economic burden of atopic dermatitis: real-world retrospective data from a large nationwide Israeli healthcare provider database. Adv Ther 2022; 39: 2502-2514.
https://doi.org/10.1007/s12325-022-02120-6 DOI: https://doi.org/10.1007/s12325-022-02120-6
Therapeutic patient education : continuing education programmes for health care providers in the field of prevention of chronic diseases : report of a WHO working group. .
Ersser SJ, Cowdell F, Latter S, Gardiner E, Flohr C, Thompson AR, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014; 7; 2014(1):CD004054.
https://doi.org/10.1002/14651858.CD004054.pub3 DOI: https://doi.org/10.1002/14651858.CD004054.pub3
Barbarot S, Stalder JF. Therapeutic patient education in atopic eczema. Br J Dermatol 2014; 170: 44-48.
https://doi.org/10.1111/bjd.12932 DOI: https://doi.org/10.1111/bjd.12932
Evers A, Duller P, Jong E, Otero ME, Verhaak CM, van der Valk PG et al. Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. Acta Derm Venereol 2009; 89: 57-63.
https://doi.org/10.2340/00015555-0556 DOI: https://doi.org/10.2340/00015555-0556
Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, et al. Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial. J Allergy Clin Immunol 2017; 140: 845-853.
https://doi.org/10.1016/j.jaci.2017.01.029 DOI: https://doi.org/10.1016/j.jaci.2017.01.029
Jaspers JPC, Span L, Molier L, Coenraads PJ. A Multimodal education and treatment program for young adults with atopic dermatitis: a randomized controlled trial. Dermatol Psychosom Dermatol Psychosom 2000; 1: 148-153.
https://doi.org/10.1159/000057970 DOI: https://doi.org/10.1159/000057970
Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin 2020; 36: 367-376.
https://doi.org/10.1080/03007995.2019.1699516 DOI: https://doi.org/10.1080/03007995.2019.1699516
Kleyn CE, Barbarot S, Reed C, Losi S, von Arx LB, Robert C, et al. Burden of moderate to severe atopic dermatitis in adults from France, Italy, and the UK: patient-reported outcomes and treatment patterns. Dermatol Ther 2022; 12: 1947-1965.
https://doi.org/10.1007/s13555-022-00777-z DOI: https://doi.org/10.1007/s13555-022-00777-z
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Marine Fargeas, Mathieu Fauvernier, Marie Tauber, Julien Seneschal, Virginie Verdu, Magali Bourrel Bouttaz, Florence Hacard, Anne-Sophie Darrigade, Audrey Nosbaum
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
